Infanrix-Ipv+hib

Haemophilus influenzae type b conjugate vaccine (tetanus toxoid conjugate) and inactivated poliovirus, the active ingredient in Infanrix-Ipv+hib, is a preventive vaccine presented as an injectable solution for intramuscular use. It is used to protect infants and young children against diphtheria, tetanus, pertussis, polio and Hib disease.

GNH USA supplies Infanrix-Ipv+hib as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix-Ipv+hib is a combination vaccine that targets bacterial and viral pathogens responsible for several childhood diseases. - Diphtheria: induces immunity against diphtheria toxin. - Tetanus: provides protection from tetanus infection. - Pertussis: prevents whooping cough caused by Bordetella pertussis. - Poliomyelitis: creates immunity to poliovirus type 3. - Haemophilus influenzae type b: prevents invasive Hib disease.

Common Side Effects: - Pain, redness or swelling at the injection site. - Low‑grade fever within 24‑48 hours. - Irritability or fussiness in infants. - Reduced appetite for a short period.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - High fever or febrile seizures. - Hypotonic‑hyporesponsive episodes. - Prolonged crying or inconsolable distress. - Encephalopathy or neurologic signs.

Infanrix-Ipv+hib should be administered only after evaluating the child's health status and vaccination history. - Allergy: Do not vaccinate if there is a known severe allergy to any vaccine component. - Acute illness: Postpone if the child has a moderate or severe febrile illness. - Immunocompromised: Use with caution; response may be reduced. - Observation: Monitor the child for at least 15 minutes after injection for immediate reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infanrix-Ipv+hib may interact with other immunizations or immune‑modulating therapies. Major Interactions (Avoid): - Live vaccines administered within 4 weeks before or after this vaccine. - Immunoglobulin or blood products containing antibodies given within 3 months. - Concurrent administration of whole‑cell pertussis vaccines. - Use with other vaccines containing the same antigens in the same visit. Moderate Interactions (Monitor Closely): - Antipyretics may mask post‑vaccination fever. - Corticosteroids may diminish immune response. - Antibiotics given at the time of vaccination could affect efficacy. - Underlying immune disorders may alter the protective response.